Compounds > valine

valine and angiotensinogen

valine has been researched along with angiotensinogen in 15 studies

Research

Studies (15)

Timeframe	Studies, this research(%)	All Research%
pre-1990	3 (20.00)	18.7374
1990's	1 (6.67)	18.2507
2000's	5 (33.33)	29.6817
2010's	6 (40.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Akahane, K; Harada, H; Iizuka, K; Kamijo, T; Kiso, Y; Kubota, T; Shimaoka, I; Umeyama, H	1
BaMaung, N; Bolis, G; Cohen, J; Dellaria, JF; Greer, J; Luly, JR; Perun, TJ; Plattner, JJ; Soderquist, J; Stein, H	1
Cohen, J; Luly, JR; Perun, TJ; Plattner, JJ; Soderquist, J; Stein, H; Yi, N	1
Cumin, F; Kelly, M; Samani, NJ; Wood, JM	1
Cheng, ZJ; Fiebeler, A; Ganten, D; Ganten, U; Lapatto, R; Luft, FC; Mervaala, EM; Müller, DN; Nurminen, K; Tikkanen, I; Vapaatalo, H	1
Amedeo Modesti, P; Bertolozzi, I; Boddi, M; Cecioni, I; Coppo, M; Formigli, L; Perna, AM; Polidori, G; Serneri, GG; Vanni, S; Zecchi-Orlandini, S	1
Dechend, R; Feldman, DL; Fiebeler, A; Garrelds, IM; Gratze, P; Jan Danser, AH; Luft, FC; Meiners, S; Müller, DN; Pilz, B; Shagdarsuren, E; Webb, RL; Wellner, M	1
Koide, N; Miyashita, Y; Murano, T; Saiki, A; Shirai, K; Watanabe, F	1
Furuno, M; Higaki, J; Horiuchi, M; Inaba, S; Iwai, M; Kanno, H; Mogi, M; Okayama, H; Senba, I; Tomono, Y	1
Chen, YD; Feng, QZ; Li, TD	1
Li, X; Qi, CJ; Xu, GL; Yuan, L	1
Furuno, M; Higaki, J; Horiuchi, M; Inaba, S; Iwai, M; Kanno, H; Mogi, M; Okayama, H; Senba, I	1
Chae, DW; Do, JY; Huh, W; Jang, HR; Kim, DJ; Kim, SG; Kim, YG; Lee, JE; Lee, YJ; Oh, HY	1
Hatou, S; Imada, T; Inaba, T; Ishida, S; Kawakami, Y; Nakamura, S; Ogawa, Y; Ozawa, Y; Shimmura, S; Tsubota, K; Yaguchi, S	1
Bader, M; Baltatu, OC; Campos, LA; Louie, P; Schumacher, C; Zaugg, CE	1

Other Studies

15 other study(ies) available for valine and angiotensinogen

Article	Year
New human renin inhibitory peptides: angiotensinogen transition-state analogues containing novel Leu-Val replacement and a retro-inverso amide bond. Chemical & pharmaceutical bulletin, 1988, Volume: 36, Issue:6 Topics: Angiotensinogen; Chemical Phenomena; Chemistry; Humans; Leucine; Renin; Valine	1988
New inhibitors of human renin that contain novel Leu-Val replacements. Examination of the P1 site. Journal of medicinal chemistry, 1988, Volume: 31, Issue:3 Topics: Amino Acid Sequence; Angiotensinogen; Binding Sites; Humans; Hydrogen-Ion Concentration; Leucine; Models, Molecular; Renin; Structure-Activity Relationship; Valine	1988
New inhibitors of human renin that contain novel Leu-Val replacements. Journal of medicinal chemistry, 1987, Volume: 30, Issue:9 Topics: Amino Acid Sequence; Angiotensinogen; Enzyme Inhibitors; Humans; Leucine; Renin; Stereoisomerism; Valine	1987
Expression of components of the RAS during prolonged blockade at different levels in primates. The American journal of physiology, 1994, Volume: 267, Issue:4 Pt 1 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Angiotensinogen; Animals; Antibodies, Monoclonal; Benzazepines; Blood Pressure; Callithrix; Female; Kidney; Liver; Male; Oligopeptides; Renin; Renin-Angiotensin System; RNA, Messenger; Tetrazoles; Time Factors; Valine; Valsartan	1994
Endothelial dysfunction and xanthine oxidoreductase activity in rats with human renin and angiotensinogen genes. Hypertension (Dallas, Tex. : 1979), 2001, Volume: 37, Issue:2 Pt 2 Topics: Acetylcholine; Angiotensin II; Angiotensinogen; Animals; Animals, Genetically Modified; Antihypertensive Agents; Dinoprost; Disease Models, Animal; Endothelium, Vascular; F2-Isoprostanes; Humans; Hypertension; Ketone Oxidoreductases; Male; Nitrates; Nitrites; Nitroprusside; Norepinephrine; Rats; Rats, Sprague-Dawley; Renal Artery; Renin; Superoxide Dismutase; Tetrazoles; Valine; Valsartan; Vasoconstrictor Agents; Vasodilation	2001
Release of preformed Ang II from myocytes mediates angiotensinogen and ET-1 gene overexpression in vivo via AT1 receptor. Journal of molecular and cellular cardiology, 2002, Volume: 34, Issue:11 Topics: Angiotensin II; Angiotensin Receptor Antagonists; Angiotensinogen; Animals; Aortic Valve Stenosis; Cardiac Catheterization; Cytoplasm; Disease Models, Animal; Endothelin-1; Gene Expression Regulation; Heart; Insulin-Like Growth Factor I; Microscopy, Confocal; Myocardium; Receptor, Angiotensin, Type 1; Receptors, Angiotensin; Renin-Angiotensin System; RNA, Messenger; Stress, Mechanical; Swine; Systole; Tetrazoles; Valine; Valsartan	2002
Aliskiren, a human renin inhibitor, ameliorates cardiac and renal damage in double-transgenic rats. Hypertension (Dallas, Tex. : 1979), 2005, Volume: 46, Issue:3 Topics: Albuminuria; Amides; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Animals, Genetically Modified; Blood Pressure; Cardiomegaly; Dose-Response Relationship, Drug; Echocardiography; Fumarates; Humans; Hypertension; Kidney; Rats; Rats, Sprague-Dawley; Renin; Tetrazoles; Valine; Valsartan	2005
Suppression of lipoprotein lipase expression in 3T3-L1 cells by inhibition of adipogenic differentiation through activation of the renin-angiotensin system. Metabolism: clinical and experimental, 2008, Volume: 57, Issue:8 Topics: 3T3-L1 Cells; Adipocytes; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Azo Compounds; Blotting, Western; Cell Differentiation; Lipoprotein Lipase; Mice; Microscopy, Phase-Contrast; Pioglitazone; PPAR gamma; Renin-Angiotensin System; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Tetrazoles; Thiazolidinediones; Valine; Valsartan	2008
Exaggeration of focal cerebral ischemia in transgenic mice carrying human Renin and human angiotensinogen genes. Stroke, 2009, Volume: 40, Issue:2 Topics: Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Brain Chemistry; Brain Ischemia; Capillaries; Cerebrovascular Circulation; Humans; Infarction, Middle Cerebral Artery; Male; Mice; Mice, Transgenic; Oxidative Stress; Receptor, Angiotensin, Type 1; Receptor, Angiotensin, Type 2; Renin; Reverse Transcriptase Polymerase Chain Reaction; Superoxides; Tetrazoles; Valine; Valsartan	2009
Endothelin-1 receptor blockade induces upregulation of renin-angiotensin-aldosterone system expression in terms of blood pressure regulation. Journal of the renin-angiotensin-aldosterone system : JRAAS, 2010, Volume: 11, Issue:2 Topics: Angiotensinogen; Animals; Antihypertensive Agents; Blood Pressure; Blotting, Northern; Endothelin A Receptor Antagonists; Kidney; Liver; Lung; Mice; Mice, Inbred C57BL; Peptidyl-Dipeptidase A; Receptor, Endothelin A; Renin; Renin-Angiotensin System; Systole; Tetrazoles; Up-Regulation; Valine; Valsartan	2010
Effects of renin-angiotensin system blockade on islet function in diabetic rats. Journal of endocrinological investigation, 2010, Volume: 33, Issue:1 Topics: Angiotensinogen; Animals; Apoptosis; Diabetes Mellitus, Experimental; Glucose Tolerance Test; In Situ Nick-End Labeling; Islets of Langerhans; Male; Nitric Oxide Synthase Type II; Perindopril; Rats; Rats, Wistar; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta1; Valine; Valsartan	2010
Temporary treatment with AT1 receptor blocker, valsartan, from early stage of hypertension prevented vascular remodeling. American journal of hypertension, 2011, Volume: 24, Issue:5 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Arteries; Blood Vessels; Disease Models, Animal; Hydralazine; Hypertension; Mice; Mice, Inbred C57BL; NADPH Oxidases; Neointima; Oxidative Stress; Renin; Tetrazoles; Valine; Valsartan	2011
Renoprotective efficacy of valsartan in chronic non-diabetic proteinuric nephropathies with renin-angiotensin system gene polymorphisms. Nephrology (Carlton, Vic.), 2011, Volume: 16, Issue:5 Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Chronic Disease; Female; Genotype; Humans; Kidney; Male; Middle Aged; Peptidyl-Dipeptidase A; Polymorphism, Genetic; Prospective Studies; Protective Agents; Proteinuria; Receptor, Angiotensin, Type 1; Renin-Angiotensin System; Tetrazoles; Transforming Growth Factor beta1; Valine; Valsartan	2011
Presence and physiologic function of the renin-angiotensin system in mouse lacrimal gland. Investigative ophthalmology & visual science, 2012, Aug-13, Volume: 53, Issue:9 Topics: Angiotensin II Type 1 Receptor Blockers; Angiotensin II Type 2 Receptor Blockers; Angiotensinogen; Animals; Cells, Cultured; Female; Fibroblasts; Imidazoles; Immunohistochemistry; Lacrimal Apparatus; Mice; Mice, Inbred BALB C; Microscopy, Fluorescence; Peptidyl-Dipeptidase A; Pyridines; Receptors, Angiotensin; Renin; Renin-Angiotensin System; RNA, Messenger; Tears; Tetrazoles; Valine; Valsartan	2012
Avosentan is protective in hypertensive nephropathy at doses not causing fluid retention. Pharmacological research, 2014, Volume: 80 Topics: Albuminuria; Angiotensin II Type 1 Receptor Blockers; Angiotensinogen; Animals; Antihypertensive Agents; Diuresis; Dose-Response Relationship, Drug; Drug Therapy, Combination; Hematocrit; Humans; Hypertension, Renal; Kidney; Male; Nephritis; Pyridines; Pyrimidines; Rats; Rats, Transgenic; Renin; Tetrazoles; Valine; Valsartan	2014